Research
Neurociencias

Psiconeuroendocrinología y Estrés en Psicosis (PSICPNEC)

Publicaciones científicas

  • Giné-Servén, E, Boix-Quintana, E, Ballesteros, A, Daví-Loscos, E, Guanyabens, N, Casado, V, Silles, S, Toll, A, Campana, M, Cuesta, MJ and Labad, J.

    Bioenergetic and early treatment response stratification (BIOERES): a two-variable prognostic model for early identification of treatment-resistance schizophrenia

    Translational Psychiatry 16(1):

    [doi:10.1038/s41398-026-03983-x]

  • Padilla, M, Varela, P, Hernandez, H, Daví, E, Ollé, I, Ragull, M, Bellon, F and Labad, J.

    Cognitive variability across the menstrual cycle in adolescent girls with ADHD: clinical profiles from a cluster analysis

    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY :

    [doi:10.1007/s00787-026-02977-w]

  • Ferrer, A, Pelegrí, A, Labad, J, Sagués, T, Salvat-Pujol, N, de Arriba-Arnau, A, Menchon, JM, Palao, D, Costas, J, Carracedo, A and Soria, V.

    Clock gene influences on sleep quality and HPA axis in major depressive disorder

    Sleep Medicine 139: 108730-108730

    [doi:10.1016/j.sleep.2025.108730]

  • Llaurador-Coll, M, Montalvo, I, Estrada, F, Sánchez-Gistau, Zetterberg, H, Labad, J, Benedet, AL and Vilella, E.

    Plasma profiles of neurology-related proteins in at-risk mental state and first-episode psychosis: Associations with psychotic symptoms and cognitive performance

    BRAIN BEHAVIOR & IMMUNITY-HEALTH 50: 101134-101134

    [doi:10.1016/j.bbih.2025.101134]

  • Avella MT, Bertho G, Giraud N, Kébir O, Caradeuc C, Labad J, Papiol S, Schulze TG, Krebs MO, Chaumette B and Frajerman A.

    Metabolomic biomarkers of psychotic conversion in ultra-high-risk subjects: a pilot study

    Translational Psychiatry 15(1): 503-503

    [doi:10.1038/s41398-025-03679-8]

  • Segura, AG, Verdolini, N, Valli, I, Garcia-Rizo, C, Diaz-Caneja, CM, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldan, A, Martinez-Aran, A, Baeza, I, Mane, A, Labad, J, Müller, DJ, Guasch-Capella, N, Bernardo, M, Mas, S, Bioque, GM, Gonzalez, J, Andrés, P, Cavone, V, Corripio, I, Duque, A, Mar-Barrutia, L, Marin, J, De-la-Camara, C, Vaquero-Puyuelo, D, Rivero, O, Fabra, MJE, Trabsa, A, Legido, T, Forte, MF, Serra-Navarro, M, de la Serna, H, Castro-Fornielles, J, Contreras, F, García-Portilla, MP, González-Blanco, L, Echevarría, RS, Rabadán, AZ, Rodriguez-Jimenez, R, Martínez-Gras, I, Usall, J, Barajas, A, Sarro, S, Pomarol-Clotet, E, Ibañez, A and Cuesta, MJ.

    Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis

    Schizophrenia Research 285: 265-275

    [doi:10.1016/j.schres.2025.09.019]

  • Gago E, Montalvo I, Tost M, Pérez S, Miñano MJ, Blasco B, Barbero JD, Estrada F, Palao D, Nadal R, Pàmias M, Soria V, García-Rizo C and Labad J.

    Psychotic-like experiences and cognitive biases in adolescents: birthweight and sex moderating effects

    Journal of Psychiatric Research 190: 425-432

    [doi:10.1016/j.jpsychires.2025.08.018]

  • Aymerich C, Pedruzo B, Salazar de Pablo G, Labad J, McCutcheon R, Pillinger T, González-Torres MÁ, Sanchez-Gistau V, Oliver D, Alonso-Alconada D, Navalón P, Sugranyes G, Vieta E, Arango C, McGuire P, Fusar-Poli P and Catalan A.

    Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis

    BRAIN BEHAVIOR AND IMMUNITY 128: 219-233

    [doi:10.1016/j.bbi.2025.04.009]

  • Montalvo, I, Delgado, JF, Rodrigo-Parés, A, Sagués, T, Berenguer-Llergo, A, Rodríguez-González, R, Bhambi, I, Pontón, P, Julià, G, Soria, V, Palao, D and Labad, J.

    Reduced SARS-CoV-2 vaccine-specific antibody response associated with high clozapine doses in schizophrenia spectrum disorders

    BRAIN BEHAVIOR & IMMUNITY-HEALTH 46: 101016-101016

    [doi:10.1016/j.bbih.2025.101016]

  • Misiak B and Labad J.

    Translational perspectives of endocrine alterations in psychosis: Are we there yet?

    Psychoneuroendocrinology 176: 107419-107419

    [doi:10.1016/j.psyneuen.2025.107419]

  • Giné-Servén E, Boix-Quintana E, Ballesteros A, Daví-Loscos E, Guanyabens N, Casado V, Martínez-Ramírez M, Crespo-Facorro B, Cuesta MJ and Labad J.

    Bioenergetic markers in cerebrospinal fluid in first-episode psychosis: Are they predictors of early antipsychotic response and 1-year outcomes?

    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 138: 111336-111336

    [doi:10.1016/j.pnpbp.2025.111336]

  • Villegas García L, Patró E, Barbero JD, Esteve-Valverde E, Palao DJ, Soria V, Labad J and Cobo J.

    Lymphocyte-derived and lipoprotein-derived inflammatory ratios as biomarkers in bipolar disorder type I: Characteristics, predictive values, and influence of current psychopharmacological treatments.

    Psychoneuroendocrinology 171: 107209-107209

    [doi:10.1016/j.psyneuen.2024.107209]

  • Ferrer A, Labad J, Salvat-Pujol N, Urretavizcaya M, Obrador-Font R, Menchón JM, Palao D, Soriano-Mas C, Costas J, Barrachina M, Carracedo Á and Soria V.

    Genetic and epigenetic changes to the glucocorticoid receptor gene (NR3C1) and cognition in major depressive disorder.

    Spanish Journal of Psychiatry and Mental Health :

    [doi:10.1016/j.sjpmh.2024.12.002]

  • Labad J, Gálvez V, Gregorio M, Palacio A, Manzano Y, Gabernet R, Borràs M, Niubó M, Silles S, Toll A, Ruiz A, Ragull M and Hernández-Ribas R.

    Assessment of prolactin levels and sexual dysfunction in patients on long-acting risperidone ISM vs monthly paliperidone palmitate.

    Spanish Journal of Psychiatry and Mental Health :

    [doi:10.1016/j.sjpmh.2025.10.001]